AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 MAY 7 - (NewsRx.com & NewsRx.net) -- A four-gene-combination DNA vaccine protected mice against a lethal vaccinia virus challenge and elicited appropriate antibody responses in nonhuman primates.
According to published research from the United States, "Two major infectious forms of vaccinia virus (VACV) have been described: the intracellular mature virion (IMV), and the extracellular enveloped virion (EEV). Due to their stability in the environment, IMVs play a predominant role in host-to-host transmission, whereas EEVs play an important role in dissemination within the host."
"In a previous report, we demonstrated that mice vaccinated with VACV L1R (IMV immunogen) and A33R (EEV immunogen) were protected from a lethal poxvirus challenge," reported Jay W. Hooper and colleagues at the United States Army Medical Research Institute for Infectious Diseases in Fort Detrick, Maryland. "Vaccination with a combination of both genes conferred greater protection than either gene alone, suggesting that an immune response against both IMV and EEV is advantageous. Here, we report that in mice individually administered DNA vaccines with two different VACV immunogens, A27L (IMV immunogen) or B5R (EEV immunogen), failed to significantly protect; however, vaccination with a combination of both genes conferred a high level of protection. Mice were completely protected when vaccinated with a combination of four ...
Source: HighBeam Research, DNA vaccine protects mice against a lethal vaccinia virus challenge.